AGTC to Present at Phacilitate Cell & Gene Therapy World 2017 – GlobeNewswire (press release)
|
AGTC to Present at Phacilitate Cell & Gene Therapy World 2017
GlobeNewswire (press release) 12, 2017 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today … |
